DCTN5
Basic information
Region (hg38): 16:23641466-23677472
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCTN5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 8 | 0 | 1 |
Variants in DCTN5
This is a list of pathogenic ClinVar variants found in the DCTN5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-23641516-C-G | Familial cancer of breast | Benign (May 13, 2019) | ||
16-23641558-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
16-23641699-A-G | Benign (Jan 10, 2019) | |||
16-23661223-G-T | not specified | Uncertain significance (Nov 28, 2024) | ||
16-23661232-A-G | not specified | Uncertain significance (Feb 12, 2024) | ||
16-23661249-T-C | not specified | Uncertain significance (Jun 13, 2024) | ||
16-23661253-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
16-23665629-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
16-23665633-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
16-23665655-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
16-23665674-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
16-23665698-C-G | not specified | Uncertain significance (Dec 14, 2023) | ||
16-23667107-G-A | not specified | Uncertain significance (Apr 07, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DCTN5 | protein_coding | protein_coding | ENST00000300087 | 6 | 28483 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00705 | 0.927 | 125730 | 0 | 18 | 125748 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 57 | 106 | 0.538 | 0.00000581 | 1190 |
Missense in Polyphen | 15 | 31.772 | 0.47212 | 302 | ||
Synonymous | 1.18 | 29 | 38.3 | 0.757 | 0.00000209 | 339 |
Loss of Function | 1.58 | 5 | 10.6 | 0.474 | 6.15e-7 | 121 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000207 | 0.000207 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000793 | 0.0000791 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Pathway
- Vasopressin-regulated water reabsorption - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;COPI-mediated anterograde transport;ER to Golgi Anterograde Transport;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.583
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.327
- hipred
- Y
- hipred_score
- 0.509
- ghis
- 0.699
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.975
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dctn5
- Phenotype
- skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); craniofacial phenotype; growth/size/body region phenotype;
Gene ontology
- Biological process
- ventricular septum development;endoplasmic reticulum to Golgi vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;aorta development;coronary vasculature development
- Cellular component
- condensed chromosome kinetochore;nucleoplasm;centrosome;cytosol;nuclear membrane
- Molecular function
- protein binding